We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

AGILENT

Agilent provides laboratories worldwide with instruments, services, consumables, applications and expertise, enabling... read more Featured Products: More products

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Flow Cytometry Of Reactive T-Cells Differentiates Lymphoproliferative Diseases

By LabMedica International staff writers
Posted on 02 Sep 2022
Print article
Image: Bone marrow aspirate from a patient with Classic Hodgkin lymphoma showing large multinucleated Reed-Sternberg cells. “Hodgkin cells” are mononuclear while “Reed-Sternberg” cells are multinucleate forms (Photo courtesy of Nidia P. Zapata, MD and Espinoza-Zamora Ramiro).
Image: Bone marrow aspirate from a patient with Classic Hodgkin lymphoma showing large multinucleated Reed-Sternberg cells. “Hodgkin cells” are mononuclear while “Reed-Sternberg” cells are multinucleate forms (Photo courtesy of Nidia P. Zapata, MD and Espinoza-Zamora Ramiro).

Classic Hodgkin lymphoma (cHL) is an unusual form of lymphoma characterized by a small number of neoplastic Hodgkin and Reed–Sternberg (HRS) cells in an extensive inflammatory background and about 90% of all Hodgkin lymphomas are this type.

In light of the frequent non-neoplastic causes of lymphadenopathy and involvement of sensitive locations, lymph node fine-needle aspiration (FNA) or core needle biopsy (CNB) as minimally invasive procedures are frequently the first alternatives to obtain lymph node tissue to diagnose lymphoproliferative disorders.

Clinical Laboratorians at the Zhejiang University School of Medicine (Hangzhou, China) included in a study cohort consisting of 125 males and 31 females with a male-to-female ratio of 4:1. The patients' ages ranged from 1 to 16, with a median age of 7.7 years. Within this cohort, 25 cases of cHL and 44 cases of reactive lymphoid hyperplasia (RLH) were evaluated for their CD3+CD45RO+T-cell population and CD7 expression on T-cells. Of the reactive cases, 13 were Epstein–Barr virus (EBV) positive.

Lymph node biopsy specimens were obtained from the patients, fixed in 10% neutral buffered formalin, and immediately sent to the pathology laboratory. Samples were prepared for staining with hematoxylin and eosin (HE), periodic acid-Schiff (PAS), and immunohistochemistry (IHC) for histopathology analysis. All immunohistochemistry staining was performed using a two-step technique with the DAKO EnVision HRP System (Agilent Technologies, Santa Clara, CA, USA). Single-cell suspensions from each lymph node were prepared according to a standard protocol. The specimens were analyzed for a range of antigens on a FACSCalibur flow cytometer (Becton Dickinson, Franklin Lakes, NJ, USA).

The investigators reported that of the suspected lymphoma cases, 55.7% (87/156) were diagnosed with non-Hodgkin lymphoma (NHL) and 16.0% (25/156) with Hodgkin lymphoma based on the histopathological features and immunohistochemical results. The NHL group consisted of 27 cases of T-lymphoblastic lymphoma (T-LBL), 10 cases of B-lymphoblastic lymphoma (B-LBL), 20 cases of Burkitt's lymphoma, nine cases of diffuse large B-cell lymphoma (DLBCL), one follicular lymphoma (FL) case, 17 anaplastic large cell lymphoma (ALCL) cases, one NK case, and two cases of NK/T lymphoma.

The overall concordance of FCI data with the histopathologic results of these cases was 81.4%. A reactive expansion of T-cells with increased expression of CD45RO was present in the reactive infiltrate of cHL (CD45RO/CD3, 67.5%) and Epstein–Barr virus (EBV) infected RLH (62.7%) but not in EBV-negative RLH (28.0%). The mean fluorescence intensity (MFI) of CD7 was higher for cHL and differed significantly from EBV-positive RLH (138.5 versus 63.8). A proposed diagnostic algorithm markedly elevated the overall concordance rate from 81.4% to 97.4%.

The authors concluded that immunophenotyping the reactive infiltrate of lymphoid tissue using flow cytometry is a reliable supplement to histopathology for the rapid diagnosis of pediatric cHL. The study was published on August 21, 2022 in the Journal of Clinical Laboratory Analysis.

 

 

Gold Supplier
Infectious Diseases Controls
Multichem ID-SeroNeg
New
HBV Test
ELISA HBV Test Kit
New
Rapid Procalcitonin (PCT) Test
AQT90 FLEX PCT Assay
New
Automated Hematology Workstation
XN-3000

Print article
IIR Middle East

Channels

Molecular Diagnostics

view channel
Image: Special blood test could determine if patient has early stage breast cancer and if the cancer is unlikely to return (Photo courtesy of USC)

Simple Blood Draw Could Revolutionize Early Breast Cancer Detection

Breast cancer is the most prevalent form of cancer in the world, affecting one in eight women over their lifetime. Since 1976 when the American Cancer Society endorsed mammography X-rays, the technique... Read more

Industry

view channel
Image: The global infectious disease IVD market is expected to hit USD 57 billion by 2030 (Photo courtesy of Pexels)

Global Infectious Disease IVD Market Dominated by Molecular Diagnostics Technology

The global infectious disease in vitro diagnostics (IVD) market stood at USD 113.7 billion in 2021 and is expected to grow at a CAGR of -7.41% from 2022 to 2030 to hit around USD 56.89 billion by 2030,... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.